Ciprofloxacin Ophthalmic Solution Recalled Nationwide for Defective Container Cap
Ciprofloxacin Ophthalmic Solution is being recalled because the cap spike is lodged in the bottle nozzle, preventing patients from accessing the medication. Affected lot 084A067 was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is a mechanical packaging defect (cap spike lodged in bottle nozzle) that prevents product access but poses no direct health risk.
Plain-English summary
FDC Limited, with distribution by Leading Pharma LLC, is recalling Ciprofloxacin Ophthalmic Solution USP 0.3% nationwide. The recall affects Lot 084A067 (expiration 12/31/2025), consisting of approximately 90,960 bottles.
The reason for the recall is a defective container: the spike of the bottle cap becomes lodged in the nozzle, preventing patients from accessing the medication inside.
Patients with affected bottles should stop using the product and contact their pharmacy for a replacement. Since this is an Rx-only medication, consultation with the prescribing healthcare provider is recommended if there are questions about treatment discontinuation or alternatives.
The recalled product
- Product
- CIPROFLOXACIN (CIPROFLOXACIN)
- Brand
- CIPROFLOXACIN
- Manufacturer
- FDC Limited
- Category
- Drug — Ophthalmic Solution
- Affected units
- 90,960
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 084A067
- Exp 12/31/2025
UPCs (2)
- 0369315308028
- 0369315308059
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CIPROFLOXACIN
- HighCiprofloxacin Ophthalmic Eye Drops Recalled Due to Defective Container
FDA (Drugs) · 2025-01-15
- ModerateCiprofloxacin Ophthalmic Solution Recalled Due to Defective Container
FDA (Drugs) · 2024-08-07
- ModerateCiprofloxacin Tablets Recalled for Foreign Material Presence
FDA (Drugs) · 2013-04-03
- LowPack Pharmaceuticals Recalls Ciprofloxacin Tablets Due to Missing Labels
FDA (Drugs) · 2012-07-25
Same manufacturer · FDC Limited
See all →- ModerateTimolol eye drop caps can lodge a spike in the nozzle
FDA (Drugs) · 2025-08-06
- ModerateTimolol Maleate Ophthalmic Solution Recalled for Defective Container
FDA (Drugs) · 2025-05-14
- ModerateTimolol Maleate eye drops recalled for defective dropper cap
FDA (Drugs) · 2025-02-12
- HighOphthalmic Eye Drops Recalled for Defective Container Cap Spike
FDA (Drugs) · 2024-12-18
- HighTimolol Maleate Eye Drops Recalled Due to Defective Container
FDA (Drugs) · 2024-11-13
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateBurkhart benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24